IT WAS reported that the Health Ministry has approved CanSino’s single-dose Convidecia vaccine to be used as a heterologous booster with all Covid-19 primary vaccines in Malaysia. Is this true?
KUALA LUMPUR: The Health Ministry has approved CanSino’s single-dose Convidecia vaccine to be used as a heterologous booster with all Covid-19 primary vaccines in Malaysia.
KUALA LUMPUR, March 21 The Ministry of Health (MOH) has approved CanSino’s single-dose Convidecia Covid-19 vaccine to be used as a heterologous booster. The MOH, in a statement on its website today, said application for the CanSino-type booster dose would be available via MySejahtera soon. It.
Asean manufacturer hopes CanSino Covid-19 vaccine included in Malaysia s booster programme | Malaysia malaymail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from malaymail.com Daily Mail and Mail on Sunday newspapers.
FILE PHOTO: Vials of a COVID-19 vaccine candidate, a recombinant adenovirus vaccine named Ad5-nCoV, co-developed by Chinese biopharmaceutical firm CanSino Biologics Inc and a team led by Chinese military infectious disease expert, are pictured in Wuhan, Hubei province, China March 24, 2020. China Daily via REUTERS
KUALA LUMPUR (Bernama): Solution Group Bhd’s (SGB) wholly-owned subsidiary, Solution Biologics Sdn Bhd (SolBio) has signed a finished product and a bulk product agreement today with CanSino Biologics Inc for the supply of the Recombinant Ad5-nCoV vaccine for use against Covid-19.
In a statement, the group said the finished product agreement allows SolBio to purchase and CanSino to supply the finish product vaccine for emergency use in Malaysia.